Methods for regualting hematopoiesis using CpG-oligonucleotides
2 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to methods for regulating hematopoiesis using CpG containing oligonucleotides. In particular, the invention relates to methods of treating thrombopoiesis and anemia by regulating hematopoiesis. The invention also relates to methods of regulating immune system remodeling by administering CpG oligonucleotides to control hematopoiesis.
169 Citations
124 Claims
-
1-65. -65. (canceled).
- 66. A method for enhancing an antigen-specific immune response to an antigen comprising administering a CpG oligonucleotide to a subject at least 48 hours prior to exposure of the subject to the antigen.
- 89. A method of immunizing a subject against an antigen comprising administering to the subject a CpG oligonucleotide at least 48 hours prior to exposing the subject to the antigen.
- 107. A method of inducing IgG2 antibody production comprising administering to a subject a CpG oligonucleotide at least 48 hours prior to administration of an antigen to the subject.
Specification